Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish
  • Turkish

Breadcrumb

  1. Home
  2. Oral microbiota, a risk factor for lung cancer?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Oral microbiota, a risk factor for lung cancer?

Oral microbiota, a risk factor for lung cancer?

Cancer
Pulmonology Otorhinolaryngology

A first prospective study conducted in never-smokers suggests a link between diversity in oral microbiota and the risk of developing lung cancer. This new insight remains to be confirmed.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

About this article

Created 13 April 2021
Updated 31 March 2022

Lung cancer is the leading cause of death by cancer worldwide. While active tobacco use is the main risk factor, 25% of cases occur in non-smokers, a high percentage not fully explained by the major risks identified (passive smoking, pollution, family history, etc.). In addition to the gut microbiota, which is involved in the development of certain gastrointestinal cancers, other microbial ecosystems have also been associated with cancer risk. In this study, the authors investigated whether the oral microbiota’s composition and its ability to colonize the respiratory tract are involved in the development of lung cancer.

Depleted microbiota, increased risk

Their prospective study involved the long-term follow-up of more than 136,000 never-smoker Shanghai residents (61,500 men, 75,000 women), with follow-up visits every 2-3 years. A saliva sample taken at the outset was analyzed in all subjects reporting lung cancer and in an identical number of controls, matched for sex, age, date and time of sample collection, previous antibiotic treatment, etc. Metagenomic shotgun sequencing was then used to compare the 114 subjects diagnosed with lung cancer with the same number of controls. This analysis found a greater risk of developing lung cancer where the oral microbiota lacks bacterial diversity.

Greater abundance of Firmicutes is harmful

The inherent composition of the oral microbiome also appears to play a major role. Among the population studied, an increase in the relative abundance of Spirochaetes and/or Bacteroidetes was associated with a lower risk of lung cancer. Conversely, a greater abundance of bacteria belonging to the Firmicutes phylum, particularly Lactobacillales, was associated with an increased risk of lung cancer. The authors point out that these results coincide with those of previous studies showing a link between Firmicutes and certain respiratory diseases (chronic obstructive pulmonary disease or COPD, squamous cell carcinoma of the head and neck, and lung cancer).

ENT microbiota: further research required to clarify its field of action

This large-scale characterization of the oral microbiota sheds new light on the causes of lung cancer in non-smokers. The geographical homogeneity of the study reinforces the relevance of its findings but limits their scope. Further work on different populations and in different locations would help clarify the role of the ENT microbiota in the development of lung cancer and other respiratory diseases.

Sources

Hosgood DH, Cai Q, Hua X, et al. Variation in oral microbiome is associated with future risk of lung cancer among never-smokers.  Thorax. 2021 Mar;76(3):256-263.

Old sources

 

 

Tags
Lung Pulmonary cancer Tobacco Oral Pulmonary

en_view en_sources

    Created 13 April 2021
    Updated 31 March 2022

    About this article

    To know more about this topic.

    Main topic

    Cancer

    Medical practice

    Pulmonology Otorhinolaryngology

    Content type

    News

    Continue reading

    News

    Antibiotic resistance: the lung microbiota pays a heavy price

    Broad-spectrum antibiotics used for treating lung infections are regarded as one of the principal contribut...

    Find out more
    Actu PRO : Moins d’antibiotiques, moins de dysbiose, moins d’asthme pédiatrique
    10.06.2020

    Fewer antibiotics, less dysbiosis, less childhood asthma

    Read the article
    14.01.2022

    Discovery of a “grey area” between bacteriostatic and bactericidal antibiotics

    Read the article
    Actu PRO : Cancer du poumon : l'influence majeure du microbiote pulmonaire
    16.04.2019

    Lung cancer: major influence of the lung microbiota

    Read the article
    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria
    02.06.2022

    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria

    Read the article
    04.04.2022

    The microbiota, a significant factor in smoking cessation

    Read the article
    Actu PRO : Comment la Covid-19 impacte-t-elle le microbiote intestinal ?
    22.12.2020

    How does Covid-19 affect the gut microbiota?

    Read the article
    Actu PRO : Covid-19 : le microbiote intestinal impliqué ?
    16.03.2021

    Covid-19: gut microbiota involved?

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish
    • Turkish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    23.01.2023

    Idiopathic urethritis in men: new infectious etiologies?

    Read the article

    Impact of beer and non alcoholic comsumption on the gut microbiota

    By Pr. Bernd SchnablDivision of Gastroenterology, San Diego Digestive Diseases Research Center (SDDRC), UC ...

    Find out more

    Skin Microbiota #17

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo